Nasopharyngeal carcinoma: significance of changes in Epstein-Barr virus-related antibody patterns following therapy.
D000914:Antibodies, Viral / Q000032:analysis; D002294:Carcinoma, Squamous Cell / Q000276:immunology* / Q000628:therapy; D005500:Follow-Up Studies; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D009303:Nasopharyngeal Neoplasms / Q000276:immunology* / Q000628:therapy; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local
D000914:Antibodies, Viral; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M